BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29992729)

  • 1. A systematic review of local excision followed by adjuvant therapy in early rectal cancer: are pT1 tumours the limit?
    Cutting JE; Hallam SE; Thomas MG; Messenger DE
    Colorectal Dis; 2018 Oct; 20(10):854-863. PubMed ID: 29992729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery.
    Borstlap WA; Coeymans TJ; Tanis PJ; Marijnen CA; Cunningham C; Bemelman WA; Tuynman JB
    Br J Surg; 2016 Aug; 103(9):1105-16. PubMed ID: 27302385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review of Local Excision After Neoadjuvant Therapy for Rectal Cancer: Are ypT0 Tumors the Limit?
    Hallam S; Messenger DE; Thomas MG
    Dis Colon Rectum; 2016 Oct; 59(10):984-97. PubMed ID: 27602930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cohort study of local excision followed by adjuvant therapy incorporating a contact X-ray brachytherapy boost instead of radical resection in 180 patients with rectal cancer.
    Smith FM; Pritchard DM; Wong H; Whitmarsh K; Hershman MJ; Sun Myint A
    Colorectal Dis; 2019 Jun; 21(6):663-670. PubMed ID: 30742736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.
    Li F; Nielsen G; Baran A; Hu J; Wallace D; Preslar M; Fleming F; Temple L; Dunne RF; Noel M; Hezel AF; Tejani MA
    Clin Colorectal Cancer; 2020 Sep; 19(3):e124-e128. PubMed ID: 32409226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
    van Oostendorp SE; Smits LJH; Vroom Y; Detering R; Heymans MW; Moons LMG; Tanis PJ; de Graaf EJR; Cunningham C; Denost Q; Kusters M; Tuynman JB
    Br J Surg; 2020 Dec; 107(13):1719-1730. PubMed ID: 32936943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single-Center Experience.
    O'Neill CH; Platz J; Moore JS; Callas PW; Cataldo PA
    Dis Colon Rectum; 2017 Feb; 60(2):152-160. PubMed ID: 28059911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
    Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
    Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Early Rectal Cancer Treatment Revisited.
    Stornes T; Wibe A; Nesbakken A; Myklebust TÅ; Endreseth BH
    Dis Colon Rectum; 2016 Jul; 59(7):623-9. PubMed ID: 27270514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.
    Li R; Wang Q; Zhang B; Yuan Y; Xie W; Huang X; Zhou C; Zhang S; Niu S; Chang H; Chen D; Miao H; Zeng ZF; Xiao W; Gao Y
    BMC Cancer; 2021 Dec; 21(1):1333. PubMed ID: 34906114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local excision of rectal carcinoma.
    Chorost MI; Petrelli NJ; McKenna M; Kraybill WG; Rodriguez-Bigas MA
    Am Surg; 2001 Aug; 67(8):774-9. PubMed ID: 11510582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of Late Recurrence Following Transanal Local Excision for Early Rectal Cancer.
    Oh BY; Yun HR; Kim SH; Yun SH; Kim HC; Lee WY; Chun HK; Cho YB
    Dis Colon Rectum; 2015 Nov; 58(11):1041-7. PubMed ID: 26445176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study.
    Arezzo A; Lo Secco G; Passera R; Esposito L; Guerrieri M; Ortenzi M; Bujko K; Perez RO; Habr-Gama A; Stipa F; Picchio M; Restivo A; Zorcolo L; Coco C; Rizzo G; Mistrangelo M; Morino M
    Tech Coloproctol; 2019 Sep; 23(9):831-842. PubMed ID: 31388861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma.
    Avila S; Chang GJ; Dasari NA; Smani DA; Das P; Herman JM; Koay E; Koong A; Krishnan S; Minsky BD; Smith GL; Taniguchi C; Taggart MW; Kaur H; Holliday EB
    Clin Colorectal Cancer; 2020 Jun; 19(2):116-122. PubMed ID: 32173279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant radiotherapy for rectal cancer management.
    Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M
    World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
    Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.